25 Oct 2016

Dr. Lee Kim Swee from the BioMed X Innovation Center: screening of regulators of myeloid cells (10 Nov. 2016, 11am)

HKU-Pasteur Research Pole and the Centre of Influenza Research of HKU will welcome Dr. Lee Kim Swee for a seminar entitled “Investigating development and function of myeloid cells using chemical and genetic screens”

Dr. Lee Kim Swee is a group leader at the recently launched BioMed X Innovation Center, Heidelberg, Germany. He obtained his PhD degree at the University of Basel, Switzerland and postdoctoral training at the Whitehead Institute for Biomedical Research/MIT, USA. Since March 2014, Dr. Swee is heading the Merck-sponsored research team at BioMed X that explores mechanisms operating in the immunosuppressive microenvironment of tumors.

"In the present study, we describe a system based on immortalized progenitors that allows straightforward investigation of myeloid cells. We performed a chemical phenotypic screening and identified 3-deazaneplanocin A as novel modulator of MDSC functions. Most importantly, this differentiation platform facilitates the identification of regulators of myeloid cells development and biology through genetic screenings."

Date:         Thursday, 10th November 2016
Time:         11:00 am.
Venue:       Rm 7-03, HKJC Building for Interdisciplinary Research
                  5 Sassoon Road, Pokfulam